Taken together, this study suggests that ICT1 may play an oncogenic role in DLBCL by promoting cell proliferation and it might be a biomarker for unfavorable prognosis in DLBCL patients. The gene discussed is MRPL58; the disease is diffuse large B-cell lymphoma.